The company
Precigen, Inc.
PGEN · Nasdaq
PGEN stood above a rising 150-day average in 42 of the last 52 weekly readings, including each of the last 19 weeks. It is 16.9% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 19 in a row
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $49K
- Insider sales, 12 months
- $68.5M
- Officials’ trades on record
- 0
- Institutions holding
- 202 (+6)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 42 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Jeffrey B. KindlerDirector | sold | 185,000at $7.44 | 26 Aug 2026filed 28 Aug 2026 |
| Phil TennantChief Commercial Officer | sold | 79,166at $7.50 | 25 Aug 2026filed 25 Aug 2026 |
| Rutul R. ShahChief Operating Officer | sold | 15,342at $7.50 | 25 Aug 2026filed 25 Aug 2026 |
| Rutul R. ShahChief Operating Officer | sold | 34,658at $7.50 | 21 Aug 2026filed 25 Aug 2026 |
| Nancy H. AgeeDirector | bought | 3,411at $7.23 | 21 Aug 2026filed 25 Aug 2026 |
| Rutul R. ShahChief Operating Officer | sold | 32,739at $6.86 | 6 Aug 2026filed 7 Aug 2026 |
| Rutul R. ShahChief Operating Officer | sold | 33,772at $6.50 | 3 Aug 2026filed 3 Aug 2026 |
| Harry Thomasian, Jr.Chief Financial Officer | sold | 100,000at $6.06 | 31 Jul 2026filed 31 Jul 2026 |
| Harry Thomasian, Jr.Chief Financial Officer | sold | 171,429at $5.53 | 1 Jul 2026filed 1 Jul 2026 |
| Helen SabzevariPresident and CEO | sold | 346,836at $5.89 | 29 Jun 2026filed 1 Jul 2026 |
| Rutul R. ShahChief Operating Officer | sold | 42,924at $5.85 | 29 Jun 2026filed 1 Jul 2026 |
| Harry Thomasian, Jr.Chief Financial Officer | sold | 28,571at $5.78 | 29 Jun 2026filed 1 Jul 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Patient Capital Management, LLCadded · filed 13 Aug 2026 | 19,036,976$108.5M | +1,219,589+6.8% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 17,146,921$97.7M | +1,923,730+12.6% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 12,002,465$68.4M | +1,112,341+10.2% |
| Diametric Capital, LPadded · filed 14 Aug 2026 | 9,269,926$52.8M | +2,468,138+36.3% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 7,906,160$45.1M | +757,164+10.6% |
| TANG CAPITAL MANAGEMENT LLCunchanged · filed 14 Aug 2026 | 6,417,500$36.6M | 00.0% |
| Boxer Capital Management, LLCadded · filed 14 Aug 2026 | 5,150,000$29.4M | +1,650,000+47.1% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 5,019,028$28.6M | +405,599+8.8% |
| IRIDIAN ASSET MANAGEMENT LLCadded · filed 29 Jul 2026 | 4,031,963$23.0M | +439,233+12.2% |
| Occam Crest Management LPreduced · filed 14 Aug 2026 | 3,605,941$19.7M | -663,110−15.5% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.